A Vitamin D Analogue Inhibits Colonic Carcinogenesis in the AOM/DSS Model

Journal of Surgical Research

Volumn 142, Issue 2, 2007, Pages 239-245

  Fichera, Alessandro ^a   Little, Nathaniel ^a   Dougherty, Urszula ^a   Mustafi, Reba ^a   Cerda, Sonia ^a   Li, Yan Chun ^a   Delgado, Jorge ^a   Arora, Amrita ^a   Campbell, Lucas K ^a   Joseph, Loren ^a   Hart, John ^a   Noffsinger, Amy ^a   Bissonnette, Marc ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

c Myc; chemoprevention; colorectal cancer; COX 2; ERK; HCA 7; inflammatory bowel diseases; vitamin D

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; DEXTRAN SULFATE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; RO 26 2198; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER MODEL; CARCINOGENESIS; CELL PROLIFERATION; COLITIS; COLON CANCER; CONTROLLED STUDY; DRUG PROTEIN BINDING; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL DIVISION; CELL LINE, TUMOR; CHOLECALCIFEROL; COLITIS; COLON; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-1BETA; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED A; PROTO-ONCOGENE PROTEINS C-MYC; UP-REGULATION;

EID: 34548677755     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.02.038     Document Type: Article

References (39)

1. Itzkowitz S.H. Colorectal cancer in inflammatory bowel disease. In: Schmiegel W., and Scholmerich J. (Eds). Colorectal cancer: Molecular mechanisms, premalignant state and its prevention (1998), Kluwer Academic Publishers, Titisee, Germany 118-126
2. Itzkowitz S.H., and Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G7
3. Ziv Y., Fazio V.W., Strong S.A., et al. Ulcerative colitis and coexisting colorectal cancer: Recurrence rate after restorative proctocolectomy. Ann Surg Oncol 1 (1994) 512
4. Meltzer S.J. Molecular genetics of ulcerative colitis-associated neoplasia. In: Schmiegel W., and Scholmerich J. (Eds). Colorectal cancer: Molecular mechanisms, premalignant state and its prevention (1998), Kluwer Academic Publishers, Titisee, Germany 107-117
5. Agoff S.N., Brentnall T.A., Crispin D.A., et al. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157 (2000) 737
6. Elson C.O., Sartor R.B., Tennyson G.S., et al. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344
7. Cooper H.S., Murthy S.N., Shah R.S., et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69 (1993) 238
8. Tessner T.G., Cohn S.M., Schloemann S., et al. Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115 (1998) 874
9. Wali R.K., Bissonnette M., Khare S., et al. 1-alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis. Cancer Res 55 (1995) 3050
10. Fichera A., Little N., Jagadeeswaran S., et al. EGFR signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res 67 (2007) 827
11. Tanaka T., Kohno H., Suzuki R., et al. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94 (2003) 965
12. Bolt M.J., Cerda S., Mustafi R., et al. Vitamin D inhibits Caco-2 cell growth: Role of vitamin D receptor and p21wafl. Gastroenterology 124 (2003) A
13. Marchiani S., Bonaccorsi L., Ferruzzi P., et al. The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells. J Cancer Res Clin Oncol 132 (2006) 408
14. Thomas M.G., Tebbutt S., and Williamson R.C. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 33 (1992) 1660
15. Thomas M.G., Nugent K.P., Forbes A., et al. Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis. Gut 35 (1994) 1718
16. Nagpal S., Na S., and Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (2005) 662
17. Zhang X., Nicosia S.V., and Bai W. Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets 6 (2006) 229
18. Han S.A., Chun H., Park C.M., et al. Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Clin Oncol (R Coll Radiol) 18 (2006) 761
19. Segditsas S., and Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25 (2006) 7531
20. Grady W.M., Myeroff L.L., Swinler S.E., et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59 (1999) 320
21. Palmer H.G., Gonzalez-Sancho J.M., Espada J., et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154 (2001) 369
22. Yanagisawa J., Yanagi Y., Masuhiro Y., et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283 (1999) 1317
23. Sun J., Hobert M.E., Duan Y., et al. Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest. Liver Physiol 289 (2005) G129
24. Sun J., Kong J., Duan Y., et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 291 (2006) E315
25. Park C.M., Reid P.E., Walker D.C., et al. A simple, practical 'swiss roll' method of preparing tissues for paraffin or methacrylate embedding. J Microsc 145 (1987) 115
26. Marsh K.A., Stamp G.W., and Kirkland S.C. Isolation and characterization of multiple cell types from a single human colonic carcinoma: Tumourigenicity of these cell types in a xenograft system. J Pathol 170 (1993) 441
27. Cerda S.R., Mustafi R., Little H., et al. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Oncogene 25 (2006) 3123
28. Sebolt-Leopold J.S., Dudley D.T., Herrera R., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5 (1999) 810
29. Pelengaris S., Khan M., and Evan G. c-MYC: More than just a matter of life and death. Nat Rev Cancer 2 (2002) 764
30. Bissonnette M., Khare S., von Lintig F.C., et al. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: Effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res 60 (2000) 4602
31. Liou H.C., and Baltimore D. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol 5 (1993) 477
32. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69 (2000) 145
33. Soloff M.S., Cook Jr. D.L., Jeng Y.J., et al. In situ analysis of interleukin-1-induced transcription of cox-2 and il-8 in cultured human myometrial cells. Endocrinology 145 (2004) 1248
34. Froicu M., Weaver V., Wynn T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17 (2003) 2386
35. Cantorna M.T., Munsick C., Bemiss C., et al. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130 (2000) 2648
36. Greenstein A.J. Cancer in inflammatory bowel disease. Mt Sinai J Med 67 (2000) 227
37. Baldassarre G., Nicoloso M.S., Schiappacassi M., et al. Linking inflammation to cell cycle progression. Curr Pharm Des 10 (2004) 1653
38. Gurlek A., Pittelkow M.R., and Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha, 25-dihydroxyvitamin D(3): Implications in cell growth and differentiation. Endocr Rev 23 (2002) 763
39. Sjoqvist U. Dysplasia in ulcerative colitis-clinical consequences?. Langenbecks Arch Surg 389 (2004) 354